PUBLISHER: The Business Research Company | PRODUCT CODE: 1939244
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939244
An arthroscopic orthopedic surgery instrument is a specialized tool used in minimally invasive joint surgeries. It allows surgeons to view, diagnose, and treat joint problems through small incisions with the help of an arthroscope. The primary goal of this instrument is to support accurate tissue repair or removal while reducing surgical trauma and encouraging quicker patient recovery.
Key types of arthroscopic orthopedic surgery instruments include arthroscopic shavers, scissors, probes, graspers, scalpels, and cannulas. Arthroscopic shavers, in particular, are used to precisely cut, shave, and remove soft or hard tissues during joint procedures. These instruments are available in various designs, such as rigid, flexible, reusable, and single-use forms. They are commonly employed in surgeries involving the knee, shoulder, hip, ankle, and elbow, and are utilized by hospitals, ambulatory surgical centers (ASCs), and orthopedic clinics.
Tariffs are impacting the arthroscopic orthopedic surgery instrument market by increasing the cost of imported surgical instruments, components, and high-precision manufacturing equipment. Segments such as arthroscopic shavers, graspers, and flexible instruments are most impacted, particularly in regions like Asia-Pacific and Europe that rely on cross-border supply chains. The tariffs have led to higher procurement costs for hospitals and orthopedic clinics but have also encouraged local production, innovation in reusable instruments, and diversification of sourcing strategies to mitigate supply chain risks.
The arthroscopic orthopedic surgery instrument market research report is one of a series of new reports from The Business Research Company that provides arthroscopic orthopedic surgery instrument market statistics, including arthroscopic orthopedic surgery instrument industry global market size, regional shares, competitors with a arthroscopic orthopedic surgery instrument market share, detailed arthroscopic orthopedic surgery instrument market segments, market trends and opportunities, and any further data you may need to thrive in the arthroscopic orthopedic surgery instrument industry. This arthroscopic orthopedic surgery instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The arthroscopic orthopedic surgery instrument market size has grown strongly in recent years. It will grow from $4.16 billion in 2025 to $4.37 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to limited availability of specialized arthroscopic instruments, reliance on traditional open surgery, rising orthopedic disorder prevalence, early adoption of knee and shoulder surgeries, growth in hospital and orthopedic clinic infrastructure.
The arthroscopic orthopedic surgery instrument market size is expected to see steady growth in the next few years. It will grow to $5.26 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to technological advancements in flexible and smart instruments, increasing use of single-use and disposable devices, growth of ambulatory surgical centers (ascs), rising demand for multi-joint arthroscopic procedures, integration of ai and digital imaging in surgical workflows. Major trends in the forecast period include rising adoption of minimally invasive surgical procedures, increasing demand for reusable and single-use instruments, expansion of arthroscopic procedures across multiple joints, integration of advanced imaging and navigation technologies, growing focus on precision and ergonomic instrument design.
The increasing prevalence of musculoskeletal disorders is expected to drive the growth of the arthroscopic orthopedic surgery instrument market in the coming years. Musculoskeletal disorders-affecting muscles, bones, joints, tendons, and ligaments-are becoming more common due to factors such as aging populations and lifestyle-related conditions. As joint degeneration and bone fragility increase with age, the demand for effective, minimally invasive surgical solutions rises. Arthroscopic orthopedic surgery instruments support this demand by enabling precise, less invasive procedures that reduce tissue damage, minimize recovery time, and improve surgical outcomes. These instruments are crucial for treating conditions such as osteoarthritis, ligament injuries, and rotator cuff tears. For instance, according to the Office for Health Improvement and Disparities, the prevalence of long-term musculoskeletal conditions in individuals aged 16 and older in the UK rose to 18.4% in 2023, up from 17.6% in 2022. This trend highlights a growing need for efficient orthopedic care solutions, underscoring the expanding role of arthroscopic instruments in modern healthcare.
Leading companies in the arthroscopic orthopedic surgery instrument market are prioritizing the development of advanced innovations, such as minimally invasive techniques that promote faster recovery, in order to improve surgical accuracy, enhance patient outcomes, and lower overall healthcare expenses. These minimally invasive techniques with faster recovery involve surgical procedures that utilize small incisions and specialized tools to minimize tissue damage, resulting in reduced pain, shorter hospital stays, and quicker return to normal activities. For example, in January 2024, Arthrex, a U.S.-based company specializing in minimally invasive surgical technologies, introduced TheNanoExperience.com, an online platform focused on patients. This approach is designed to alleviate pain and speed up recovery, allowing individuals to return to their routines more quickly. The platform also includes comprehensive videos, patient testimonials, and procedure descriptions to support informed decision-making.
In February 2023, Zimmer Biomet Holdings Inc., a U.S.-based medical device company, acquired Embody Inc. for $275 million. This acquisition enhances Zimmer Biomet's presence in sports medicine and arthroscopic orthopedic surgery by incorporating Embody's innovative soft tissue healing technologies into its product lineup. Embody Inc. is a U.S.-based medical device firm that specializes in instruments for soft tissue repair used in arthroscopic orthopedic surgery.
Major companies operating in the arthroscopic orthopedic surgery instrument market are Johnson and Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith and Nephew plc, Arthrex Inc, Karl Storz SE and Co KG, Integra LifeSciences Holdings Corporation, CONMED Corporation, B Braun Melsungen AG, Gauthier Biomedical Inc, Sklar Surgical Instruments Inc, Medicon eG, Millennium Surgical Corp, Rudolf Medical GmbH and Co KG, Devesh Meditech Pvt Ltd, GPC Medical Ltd, Olympus Medical Systems, Surgical Holdings Ltd, Smiths Medical
North America was the largest region in the arthroscopic orthopedic surgery instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arthroscopic orthopedic surgery instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the arthroscopic orthopedic surgery instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The arthroscopic orthopedic surgery instrument market consists of sales of dilators, cannulated instruments, suture anchors, shavers, burrs, punches, graspers, probes, scissors, cannulas, fluid management systems, and specialized surgical tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Arthroscopic Orthopedic Surgery Instrument Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses arthroscopic orthopedic surgery instrument market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for arthroscopic orthopedic surgery instrument ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The arthroscopic orthopedic surgery instrument market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.